Company: CERO
Filing Date: 2025-01-07
Form Type: 424B3
Source: 0001213900-25-001658
Chunk: 10

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-07
Form: 424B3
Chunk 10
---
 time to time, and it is not possible to predict all such risk factors, nor can the Company assess the impact of all such risk factors
on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those
contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance
on these statements, which speak only as of the date hereof. All forward-looking statements made by the Company or persons acting on its
behalf are expressly qualified in their entirety by the foregoing cautionary statements. The Company undertakes no obligation to update
or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required
by law.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

| Exhibit No. 
 3.1         
 99.1        |     | Description                                                                                                                  
 Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of CERo Therapeutics Holdings, Inc. 
 Press release, dated January 6, 2025.                                                                                        |
|:------------|:----|:-----------------------------------------------------------------------------------------------------------------------------|
| 104         |     | Cover Page Interactive Data File (Embedded within the Inline XBRL Document).                                                 |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: January 6, 2025 | CERO THERAPEUTICS HOLDINGS, INC. |                         |
|:----------------------|:---------------------------------|:------------------------|
|                       | By:                              | /s/ Chris Ehrlich       |
|                       | Name:                            | Chris Ehrlich           |
|                       | Title:                           | Chief Executive Officer |

<div align='center'>3</div>